Literature DB >> 23633269

Lipoproteins are an important bacterial component responsible for bone destruction through the induction of osteoclast differentiation and activation.

Jiseon Kim1, Jihyun Yang, Ok-Jin Park, Seok-Seong Kang, Woo-Shin Kim, Kenji Kurokawa, Cheol-Heui Yun, Hong-Hee Kim, Bok Luel Lee, Seung Hyun Han.   

Abstract

Bacterial infection can cause inflammatory bone diseases accompanied by the bone destruction resulting from excess generation of osteoclasts. Although lipoproteins are one of the major immunostimulating components of bacteria, little is known about their effects on bone metabolism. In this study, we investigated the role of lipoproteins in bacteria-induced bone destruction using Staphylococcus aureus wild type, its lipoprotein-deficient mutant, and synthetic lipopeptides Pam2CSK4 and Pam3CSK4 known to mimic bacterial lipoproteins. Formaldehyde-inactivated S. aureus or the synthetic lipopeptides induced severe bone loss in the femurs of mice after intraperitoneal administration and in a calvarial bone implantation model, whereas the lipoprotein-deficient S. aureus did not show such effects. Mechanism studies further identified three action mechanisms for the lipopeptide-induced osteoclast differentiation and bone resorption via (i) enhancement of osteoclast differentiation through Toll-like receptor 2 and MyD88-dependent signaling pathways; (ii) induction of pro-inflammatory cytokines, TNF-α and IL-6; and (iii) upregulation of RANKL expression with downregulation of osteoprotegerin expression in osteoblasts. Taken together, these results suggest that lipoprotein might be an important bacterial component responsible for bone destruction during bacterial infections through augmentation of osteoclast differentiation and activation.
© 2013 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BACTERIAL LIPOPROTEIN; BONE RESORPTION; LIPOPEPTIDE; OSTEOCLAST DIFFERENTIATION; TLR2

Mesh:

Substances:

Year:  2013        PMID: 23633269     DOI: 10.1002/jbmr.1973

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  33 in total

Review 1.  Lipoproteins of Gram-Positive Bacteria: Key Players in the Immune Response and Virulence.

Authors:  Minh Thu Nguyen; Friedrich Götz
Journal:  Microbiol Mol Biol Rev       Date:  2016-08-10       Impact factor: 11.056

2.  Porphyromonas gingivalis Stimulates Bone Resorption by Enhancing RANKL (Receptor Activator of NF-κB Ligand) through Activation of Toll-like Receptor 2 in Osteoblasts.

Authors:  Ali Kassem; Petra Henning; Pernilla Lundberg; Pedro P C Souza; Catharina Lindholm; Ulf H Lerner
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

3.  Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures.

Authors:  Sofia Movérare-Skrtic; Petra Henning; Xianwen Liu; Kenichi Nagano; Hiroaki Saito; Anna E Börjesson; Klara Sjögren; Sara H Windahl; Helen Farman; Bert Kindlund; Cecilia Engdahl; Antti Koskela; Fu-Ping Zhang; Emma E Eriksson; Farasat Zaman; Ann Hammarstedt; Hanna Isaksson; Marta Bally; Ali Kassem; Catharina Lindholm; Olof Sandberg; Per Aspenberg; Lars Sävendahl; Jian Q Feng; Jan Tuckermann; Juha Tuukkanen; Matti Poutanen; Roland Baron; Ulf H Lerner; Francesca Gori; Claes Ohlsson
Journal:  Nat Med       Date:  2014-10-12       Impact factor: 53.440

Review 4.  Innate Immunity to Staphylococcus aureus: Evolving Paradigms in Soft Tissue and Invasive Infections.

Authors:  Stephanie L Brandt; Nicole E Putnam; James E Cassat; C Henrique Serezani
Journal:  J Immunol       Date:  2018-06-15       Impact factor: 5.422

5.  Astragalus polysaccharide attenuates LPS-related inflammatory osteolysis by suppressing osteoclastogenesis by reducing the MAPK signalling pathway.

Authors:  Jianye Yang; Leilei Qin; Jiaxing Huang; Yuwan Li; Sha Xu; Hai Wang; Sizheng Zhu; Jiawei Wang; Bo Zhu; Feilong Li; Wei Huang; Xuan Gong; Ning Hu
Journal:  J Cell Mol Med       Date:  2021-06-02       Impact factor: 5.310

6.  Lipoproteins Cause Bone Resorption in a Mouse Model of Staphylococcus aureus Septic Arthritis.

Authors:  Michelle Schultz; Majd Mohammad; Minh-Thu Nguyen; Zhicheng Hu; Anders Jarneborn; Carina M Wienken; Matti Froning; Rille Pullerits; Abukar Ali; Heiko Hayen; Friedrich Götz; Tao Jin
Journal:  Front Microbiol       Date:  2022-03-09       Impact factor: 5.640

7.  A 15-amino acid C-terminal peptide of beta-defensin-3 inhibits bone resorption by inhibiting the osteoclast differentiation and disrupting podosome belt formation.

Authors:  Ok-Jin Park; Jiseon Kim; Ki Bum Ahn; Jue Yeon Lee; Yoon-Jeong Park; Kee-Yeon Kum; Cheol-Heui Yun; Seung Hyun Han
Journal:  J Mol Med (Berl)       Date:  2017-09-09       Impact factor: 4.599

8.  Oridonin ameliorates inflammation-induced bone loss in mice via suppressing DC-STAMP expression.

Authors:  Bin-Hua Zou; Yan-Hui Tan; Wen-de Deng; Jie-Huang Zheng; Qin Yang; Min-Hong Ke; Zong-Bao Ding; Xiao-Juan Li
Journal:  Acta Pharmacol Sin       Date:  2020-08-04       Impact factor: 6.150

Review 9.  Staphylococcus aureus vs. Osteoblast: Relationship and Consequences in Osteomyelitis.

Authors:  Jérôme Josse; Frédéric Velard; Sophie C Gangloff
Journal:  Front Cell Infect Microbiol       Date:  2015-11-26       Impact factor: 5.293

10.  Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL.

Authors:  Ali Kassem; Catharina Lindholm; Ulf H Lerner
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.